Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20798785 | 0.82 | ALDH1A1 (0.34) | THRBTSHRALDH1A1 | |
| SCHEMBL27619091 | 0.81 | ALDH1A1 (0.46) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL824318 | 0.81 | GAA (0.42) | GAAMGAMSIMGAM2THRB | |
| SCHEMBL13559183 | 0.79 | GAA (0.41) | GAAMGAMSIMGAM2THRB | |
| SCHEMBL26002905 | 0.79 | TSHR (0.32) | THRBTSHR | |
| SCHEMBL28077715 | 0.79 | ALDH1A1 (0.41) | GAATHRBTSHRALDH1A1 | |
| SCHEMBL5176405 | 0.79 | ALDH1A1 (0.41) | GAATHRBTSHRALDH1A1 | |
| SCHEMBL20629674 | 0.77 | ALDH1A1 (0.39) | GAATHRBTSHRALDH1A1 | |
| SCHEMBL10773330 | 0.77 | GAA (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL347723 | 0.77 | ALDH1A1 (0.42) | GAATHRBTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10946100-B2 | Polymers including active agents | MICROVENTION, INC. (US) | 2021-03-16 | — | — | US | disclosed |
| US-20190151452-A1 | Polymers Including Active Agents | MICROVENTION, INC. | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151452-A1 | Polymers Including Active Agents | MFAP1, VCL, ACTB | GAA 1874/4885MGAM 426/4885SI 4188/4885 |
| US-10946100-B2 | Polymers including active agents | MFAP1, VCL, ACTB | GAA 1874/4885MGAM 426/4885SI 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.